Ben Chiarelli is the co-founder and CEO of Cellibre. Cellibre is a cellular agriculture company that employs an organism-agnostic approach to turn cells into specialized, sustainable factories for the manufacture of globally significant products at scale. He is also the Founder, and Managing Partner of Divitempus Ventures, a venture capital and private equity firm that’s focused on investing time to create value. 

Ben has held roles at Synthetic Genomics, Millennium Health, and spent nearly a decade with JP Morgan's Healthcare Investment Banking Group where he executed over $20...